[HTML][HTML] Mechanisms of SARS-CoV-2 entry into cells
The unprecedented public health and economic impact of the COVID-19 pandemic caused
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …
Nanotechnology-based strategies against SARS-CoV-2 variants
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already infected more
than 500 million people globally (as of May 2022), creating the coronavirus disease 2019 …
than 500 million people globally (as of May 2022), creating the coronavirus disease 2019 …
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies
T Tada, H Zhou, BM Dcosta, MI Samanovic… - …, 2022 - thelancet.com
Background SARS-CoV-2 vaccines currently authorized for emergency use have been
highly successful in preventing infection and lessening disease severity. The vaccines …
highly successful in preventing infection and lessening disease severity. The vaccines …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Comparison of neutralizing antibody titers elicited by mRNA and adenoviral vector vaccine against SARS-CoV-2 variants
T Tada, H Zhou, MI Samanovic, BM Dcosta… - BioRxiv, 2021 - biorxiv.org
The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and …
decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and …
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Monoclonal antibodies (mAbs) are a focus in vaccine and therapeutic design to counteract
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. Here, we …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants. Here, we …
[HTML][HTML] Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy
The effect of SARS-CoV-2 infection on placental function is not well understood. Analysis of
placentas from women who tested positive at delivery showed SARS-CoV-2 genomic and …
placentas from women who tested positive at delivery showed SARS-CoV-2 genomic and …
B. 1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies
H Zhou, BM Dcosta, MI Samanovic, MJ Mulligan… - MBio, 2021 - Am Soc Microbiol
ABSTRACT DNA sequence analysis recently identified the novel SARS-CoV-2 variant B.
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …
1.526 that is spreading at an alarming rate in the New York City area. Two versions of the …
Protective neutralizing epitopes in SARS‐CoV‐2
H Liu, IA Wilson - Immunological reviews, 2022 - Wiley Online Library
The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden
worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has …
worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has …
Potential detrimental role of soluble ACE2 in severe COVID‐19 comorbid patients
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) enters the host cell by
binding to angiotensin‐converting enzyme 2 (ACE2) receptor. Other important proteins …
binding to angiotensin‐converting enzyme 2 (ACE2) receptor. Other important proteins …